Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01342315 · ClinicalTrials.gov registry record · Phase 3
Topical Antifungal Treatment for Tinea Cruris
A Phase 3 study, sponsored by Medicis Global Service Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 483
- Enrollment target
NCT01342315 is a Phase 3 study that has completed, run by Medicis Global Service Corporation. The registered enrollment target is 483 participants.
The verdict
NCT01342315, a Phase 3 study, has completed, sponsored by Medicis Global Service Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 483 participants
- Enrollment target
Study Summary
To determine if a topical antifungal cream is safe and effective for the treatment of tinea cruris
Interventions
- DRUG Placebo
- DRUG 33525
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 483 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-05 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01342315
The ClinicalTrials.gov registry entry for NCT01342315 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 483 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medicis Global Service Corporation, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01342315 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01342315 about?
NCT01342315 is a clinical study titled "Topical Antifungal Treatment for Tinea Cruris". To determine if a topical antifungal cream is safe and effective for the treatment of tinea cruris
What is the current status of trial NCT01342315?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 483 participants. The study started on 2011-05. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01342315?
The interventions under investigation include: Placebo (DRUG), 33525 (DRUG).
Who is sponsoring clinical trial NCT01342315?
This trial is sponsored by Medicis Global Service Corporation, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.